KH
72
Investments
0
Exits
—
AUM
0.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Kinam Hong.
Investment Thesis & Strategy
Kinam Hong, as a partner at Sofinnova Partners, invests in various stages of biotech companies, seeking innovative solutions within the healthcare sector.
Portfolio Companies
Selected investments from their portfolio of 72 companies
P
POLYNEURON
Other · , 0
R
Rgenix
Other · , 0
S
Synthace
Other · , 0
Z
Zyl
Other · , 0
B
Biosyntia
Other · , 0
C
Checkmate Pharmaceuticals
Other · , 0
A
AFYREN
Other · , 0
M
MISSION Therapeutics
Other · , 0
M
Myricx Pharma
Other · , 0
C
CelluComp
Other · , 0
C
Corvidia
Other · , 0
R
ReCor Medical
Other · , 0
Frequently Asked Questions
Kinam Hong focuses on Seed stage investments.